ENDRA Life Sciences (NDRA) executive Thornton received 68,066 Stock Options
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Michael Milos Thornton (executive at ENDRA Life Sciences Inc., NDRA) reported that they received 68,066 Stock Options on Jan 30, 2023.
- Reporting person
- Thornton Michael Milos
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 30, 2023 | Grant or award (A) | Stock OptionsOn 68,066 Common Stock1 | +68,066 | - | - | 68,066 direct |
Holdings before and after
- Stock Options: 0 to 68,066 direct
Footnotes from the filing
- 1. This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Thornton report in this NDRA Form 4?
Michael Milos Thornton (executive at ENDRA Life Sciences Inc., NDRA) reported that they received 68,066 Stock Options on Jan 30, 2023.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for NDRA
Earlier insider filings at NDRA
- Dec 13, 2022SEC Form 4: Thornton Michael Milos bought $5,100 worth of shares (1,500 units at $3.40), increasing direct ownership by 9% to 19,139 units
- Nov 28, 2022SEC Form 4: Tokman Alexander Y bought $1,700 worth of shares (10,000 units at $0.17), increasing direct ownership by 7% to 162,857 units
- Aug 24, 2022SEC Form 4: Thornton Michael Milos bought $5,400 worth of shares (20,000 units at $0.27), increasing direct ownership by 6% to 352,775 units
- Aug 24, 2022SEC Form 4: Tokman Alexander Y bought $5,200 worth of shares (20,000 units at $0.26), increasing direct ownership by 15% to 152,857 units
- May 31, 2022SEC Form 4: Thornton Michael Milos bought $5,250 worth of shares (25,000 units at $0.21), increasing direct ownership by 8% to 332,775 units
Quantisnow market dataNASDAQ
NDRA
ENDRA Life Sciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2017
Get push alerts for NDRA
Full NDRA profile on Quantisnow Follow NDRA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time